Your cart is currently empty!

Tesamorelin (TH9507) – 2 mg
Tesamorelin (TH9507) – an effective growth hormone releasing factor (GRF, SRN) and metabolism promoter. This peptide increases the rate of HGH production and significantly improves especially metabolism and nutrient transport.
Description
Tesamorelin (TH9507) – an effective growth hormone releasing factor (GRF, SRN) and metabolism promoter. This peptide increases the rate of HGH production and significantly improves especially metabolism and nutrient transport. Thanks to Tesamorelin you can quickly reduce the level of body fat around your waist, as well as streamline the body’s energy use, stimulate rapid ATP replenishment in the muscles, and overall improve the shape and lipid profile of your body. The main and most common use of Tesamorelin is in treating metabolic diseases and disorders, and breaking down fat accumulated in the waist and abdominal area.
Tesamorelin – inhibits the growth and development of infection in HIV-positive patients. Similarly, it is also used to treat people with lipodystrophy (a disease in which the body’s fat stores are poorly distributed and massively accumulated in one place/parts of the body), or to treat similar diseases and serious metabolic disorders. Tesamorelin simultaneously prevents further fat deposition, mainly in the abdomen and abdominal cavity. Main effect Effectively breaks down fat accumulated in the waist and abdominal area, and prevents its re-accumulation It is the best treatment for metabolic diseases and disorders Improves memory and learning ability, supports brain function Causes improvement in mental alertness and activity, and cognitive abilities (e.g. Benefits and advantages Tesamorelin Strengthens and heals the nervous system Recommended use and dosage Is 150-300 mcg 3 times a day in evenly spaced doses, to be applied subcutaneously (subcutaneously) in the abdomen (preferably in the area below the navel, or where the accumulated fat is thickest).
Tesamorelin is a peptide that is considered a Growth Hormone Releasing Hormone (GHRH) agonist, found to reduce levels of abdominal fat as well as HIV-induced lipodystrophy. When administered subcutaneously, tesamorelin is found to increase levels of glucose and lipid metabolism.
The peptide is a synthetically made polypeptide composed of 44 amino acids. The peptide differs from natural GHRH as it has been modified for optimal stability by manipulating the N terminus of the compound. Due to its similarity to GHRH, tesamorelin prompts release of Growth Hormone (GH) from the pituitary gland to act on various cells in the body. Additionally, the GH release triggers hepatocytes to secrete IGF-1 which assists in the regulation of overall growth, cell death, and lipolysis [1].
Main Research Findings
1) Tesamorelin has the potential to improve the quality of fat regardless of whether any changes in fat quantity occur.
2) Levels of visceral adipose tissue significantly decreased in ART-treated HIV patients after administration of tesamorelin
Reviews
There are no reviews yet.